Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome
Sign Up to like & getrecommendations! Published in 2023 at "EFSA Journal"
DOI: 10.2903/j.efsa.2023.7744
Abstract: Abstract Development of adverse outcome pathways (AOPs) for uterine adenocarcinoma can provide a practical tool to implement the EFSA‐ECHA Guidance (2018) for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012… read more here.
Keywords: outcome; development; uterine adenocarcinoma; aop network ... See more keywords
Metastatic Uterine Adenocarcinoma in a Sable Antelope (Hippotragus niger)
Sign Up to like & getrecommendations! Published in 2022 at "Veterinary Sciences"
DOI: 10.3390/vetsci9070339
Abstract: Simple Summary A female sable antelope with a history of gradual loss of body condition was found dead by the owner. Macroscopic examination revealed an enlarged spleen and liver that were covered in white-to-cream-coloured nodules.… read more here.
Keywords: sable antelope; tumour cells; microscopy; neoplastic cells ... See more keywords